BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 28535626)

  • 21. Colony Stimulating Factor-1 and its Receptor in Gastrointestinal Malignant Tumors.
    Li HW; Tang SL
    J Cancer; 2021; 12(23):7111-7119. PubMed ID: 34729112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors including clinical markers.
    Glimelius B
    Cancer Treat Res; 1989; 41():89-96. PubMed ID: 2577091
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
    Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
    [No Abstract]   [Full Text] [Related]  

  • 24. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma.
    Yang LQ; Wang L; Zuo LK; Ma ZP; Yan SF; Yang MH; Liu B; Li XX
    Pathol Res Pract; 2022 Mar; 231():153781. PubMed ID: 35121362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms.
    Kushekhar K; van den Berg A; Nolte I; Hepkema B; Visser L; Diepstra A
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2737-47. PubMed ID: 25205514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Biomarker Approaches in Classic Hodgkin Lymphoma.
    Aoki T; Steidl C
    Cancer J; 2018; 24(5):206-214. PubMed ID: 30247255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory microenvironment in classical Hodgkin's lymphoma with special stress on mast cells.
    Ribatti D; Tamma R; Annese T; Ingravallo G; Specchia G
    Front Oncol; 2022; 12():964573. PubMed ID: 36313712
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.